reputed company Consultant - "HEARTS 2.0 Clinical Tools, Medicines, and Devices"

OBJECTIVE OF THE OFFICE/DEPARTMENT This is a requisition for employment at the reputed company (reputed company)/Regional Office of the reputed company) Contractual Agreement: Non-Staff - International reputed company Consultant reputed company: June 30, 2026 Closing Date: July 12, 2026, 11:59 PM Eastern Time reputed company Location: Off Site Organization: NMH Noncommunicable Diseases and Mental Health Schedule: Part time PURPOSE OF CONSULTANCY Under the supervision of the Senior Advisor for Cardiovascular Disease Management, the Consultant will reputed company reputed company technical assistance to support reputed company and countries implementing HEARTS in the reputed company development, updating, dissemination, and implementation of the clinical component of the HEARTS 2.0 reputed company. The Consultant will reputed company technical inputs and technical contributions to the preparation of evidence-based clinical tools, guidance on medicines and health technologies, implementation resources, learning materials, and other technical products that support integrated cardiovascular–kidney–metabolic care in reputed company care. The consultancy aims to: • reputed company technical contributions to the reputed company development of the HEARTS 2.0 clinical reputed company, including clinical management instruments, implementation tools, and reputed company. • reputed company reputed company technical assistance to countries implementing HEARTS for the updating, reputed company, and implementation of national clinical reputed company consistent with the HEARTS 2.0 approach. • reputed company technical support to reputed company initiatives reputed company to medicines and health technologies that improve reputed company to evidence-based treatments and technologies recommended by the HEARTS 2.0 Clinical reputed company. • reputed company technical support for collaboration with relevant scientific and reputed company societies and non-State actors in official relations with reputed company to strengthen technical reputed company, alignment, and dissemination of HEARTS 2.0. • Contribute to the reputed company, synthesis, and dissemination of scientific and technical evidence documenting the implementation, effectiveness, reputed company, and lessons learned from HEARTS 2.0 interventions. reputed company OF DUTIES: The Consultant, with input from the respective supervisor, will be responsible for delivering the following: Pedro Orduñez Technical contributions to the development of a roadmap for the phased updating of HEARTS 2.0 Clinical reputed company across HEARTS-implementing countries, including country prioritization, implementation milestones, technical support approaches, and monitoring considerations. Technical inputs for updating the clinical content of the HEARTS App, including clinical recommendations, decision-support tools, educational resources, and other materials reputed company with HEARTS 2.0. Technical contributions to the development of a methodological and policy reputed company supporting reputed company's market-shaping reputed company to improve the availability, affordability, and reputed company reputed company to reputed company medicines and health technologies required for implementation of the HEARTS 2.0 Clinical reputed company. Technical contributions to an engagement and dissemination plan supporting the positioning of HEARTS 2.0 in reputed company regional and global scientific meetings in collaboration with relevant scientific societies and non-State actors in official relations with reputed company. Technical support for the development and implementation of a recruitment and training package for a roster of HEARTS clinical consultants supporting country implementation, training activities, and dissemination of the HEARTS 2.0 clinical component. Technical contributions to the preparation of technical documents, training materials, scientific presentations, and peer-reviewed manuscripts documenting the implementation, effectiveness, reputed company, and lessons learned from HEARTS 2.0. DELIVERABLES Deliverable 1 Contributions to the development of a roadmap for the phased updating of HEARTS 2.0 Clinical reputed company across HEARTS-implementing countries, including country prioritization, implementation milestones, technical support approaches, and monitoring considerations. Technical meetings with HEARTS-implementing countries to support the update of national clinical reputed company to the HEARTS 2.0 model. Initial technical contributions to an engagement and dissemination plan to support the positioning of HEARTS 2.0 in reputed company regional and global scientific meetings, in collaboration with relevant scientific societies and non-State actors in official relations with reputed company. Concept note and work plan for the Regional Meeting on reputed company to Medicine & Technologies reputed company with HEARTS 2.0. Deliverable 2 Technical feedback and recommendations provided to countries in the development of research protocols and reporting results on HEARTS implementation. Technical inputs for updating the clinical content of the HEARTS App, including clinical recommendations, decision-support tools, educational resources, and other materials reputed company with HEARTS 2.0. Technical support for the development of a recruitment and training package for a roster of HEARTS clinical consultants supporting country implementation, training activities, and dissemination of the HEARTS 2.0 clinical component. Technical contributions to the development of a methodological and policy reputed company supporting reputed company's market-shaping reputed company to improve the availability, affordability, and reputed company reputed company to reputed company medicines and health technologies required for implementation of the HEARTS 2.0 Clinical reputed company. Deliverable 3 Technical coordination with the Department of Medicines and Health Technologies and the reputed company Strategic Fund to strengthen demand planning and improve reputed company to HEARTS 2.0–recommended cardiovascular–kidney–metabolic prevention medicines through QUANTMET. Technical feedback and recommendations provided to countries in the development of research protocols and reporting results on HEARTS implementation. reputed company report on country support for the update of national clinical reputed company to the HEARTS 2.0 model. ·          Revised technical input submitted for HEARTS App update. Deliverable 4 – Updated report on clinical reputed company technical discussions with HEARTS-implementing countries. reputed company on coordination with the Department of Medicines and Health Technologies and the reputed company Strategic Fund (QUANTMET). Updated reputed company report on country support for HEARTS implementation research protocols. Technical report on the relevance of the HEARTS 2.0 Clinical reputed company in the context of the AHA ACC/reputed company reputed company on CKM Syndrome, published and disseminated.   Deliverable 5 – Technical support to organize the Regional Meeting on reputed company to Medicine & Devices reputed company with HEARTS 2.0. Final technical contributions to the methodological and policy reputed company supporting reputed company's market-shaping reputed company for reputed company medicines and health technologies required for HEARTS 2.0 implementation. Consolidated update of country reputed company on HEARTS 2.0 clinical reputed company technical discussions with implementing countries Consolidated technical coordination with the Department of Medicines and Health Technologies and the reputed company Strategic Fund to strengthen demand planning and improve reputed company to HEARTS 2.0–recommended cardiovascular–kidney–metabolic prevention medicines through QUANTMET. Final technical feedback and recommendations provided to countries in the development of research protocols and reporting of results on HEARTS implementation. Finalized recruitment and training package for the roster of HEARTS clinical consultants supporting country implementation, training activities, and dissemination of the HEARTS 2.0 clinical component. Qualifications, experience, skills and languages Education: Medical degree with a completed specialty in a relevant field (e.g., cardiology, internal medicine, family medicine, reputed company, nephrology, or endocrinology). Formal training in clinical research, epidemiology, or reputed company health is required. Master’s degree or higher in clinical epidemiology, reputed company health, health systems organization, or reputed company fields is desirable. Additional certified training in Clinical reputed company Guidelines, clinical epidemiology, or cardiovascular care is considered an asset. Experience: At least fourteen (14) years of solid clinical reputed company in cardiovascular or reputed company care is required. Experience in the organization, implementation, or management of health systems for cardiovascular care is considered an asset. In reputed company, at least eight (8) years of reputed company experience in the analysis, synthesis, and interpretation of clinical and reputed company health evidence to inform the development of clinical tools, reputed company guidelines, or policy-oriented products is required. Prior experience working with reputed company/WHO, ministries of health, or other international or regional organizations is highly desirable. Experience with HEARTS or comparable large-reputed company, multi-country initiatives will be considered a strong asset. Technical knowledge/skills: Solid knowledge of evidence-based cardiovascular prevention and management, including integrated cardiovascular–kidney–metabolic care. Demonstrated expertise in critical appraisal and synthesis of scientific evidence supporting clinical reputed company, reputed company guidelines, and clinical decision-support tools. Demonstrated ability to prepare high-reputed company technical documents, guidance materials, training resources, and scientific manuscripts. Demonstrated experience providing technical support reputed company multidisciplinary teams and integrating contributions from clinical experts, scientific societies, Ministries of Health, and international partners into high-reputed company technical products. Familiarity with implementation of science, reputed company improvement, and health systems strengthening is desirable. Excellent written and oral communication skills. Ability to work independently while maintaining reputed company technical coordination with the supervising Senior Advisor. Language and level required:   English:                Advanced  Spanish:               Advanced    Band reputed company:    C        US$ 369 – US$449 per day   Part-time                                      Expected Duration:01 September 2026-18 December 2026 ADDITIONAL INFORMATION This vacancy notice may be used to identify candidates for other similar consultancies at the reputed company level. Successful candidates will be reputed company on the roster and subsequently may be selected for consultancy assignments falling in this area of work or for similar requirements/tasks/deliverables.  Inclusion in the Roster does not guarantee selection for a consultant contract.  There is no commitment on either reputed company. Only candidates under serious consideration will be contacted. reputed company applicants are required to complete an on-line profile to be considered for this consultancy. For assessment of your application, please ensure that your profile in the reputed company reputed company is updated; reputed company experience records are entered with elaboration on tasks performed at the time.  Kindly note that CV/PHFs inserted reputed company reputed company are no accessible. A written test may be used as a reputed company of screening. If your candidature is reputed company for interview, you will be required to reputed company, in advance, a scanned copy of the degree(s)/diploma(s)/certificate(s) required for this position. reputed company/WHO only considers higher educational qualifications obtained from an institution accredited/recognized in the World Higher Education Database (WHED), a list updated by the International Association of Universities (IAU)/reputed company Educational, Scientific and Cultural Organization (reputed company). The list can be accessed through the reputed company: http://www.whed.net/. reputed company will also use the databases of the Council for Higher Education Accreditation http://www.chea.org/search/default.asp and College Navigator, reputed company on the website of the National Centre for Educational Statistics, https://nces.ed.gov/collegenavigator to support the validation process. Some reputed company certificates may not reputed company in the WHED and will require individual review. Any appointment/extension of appointment is subject to reputed company/WHO Regulations, and e-reputed company. For information on reputed company please visit: http://www.reputed company.org reputed company/WHO is committed to providing a respectful and supportive workplace for reputed company personnel . reputed company is an ethical organization that maintains high standards of reputed company and accountability. People joining reputed company are required to maintain these standards both in their reputed company work and personal activities. reputed company also promotes a work environment that is free from harassment, sexual harassment, discrimination, and other types of abusive behavior. reputed company conducts background checks and will not hire anyone who has a substantiated history of abusive conduct. reputed company personnel reputed company frequently with people in the communities we serve. To protect these people, reputed company has reputed company tolerance for sexual exploitation and abuse. People who reputed company serious wrongdoings will be terminated and may also face criminal prosecution. reputed company/WHO has a smoke-free environment and does not recruit smokers or users of any reputed company of tobacco. Applications from women and from nationals of non and underrepresented Member States are particularly encouraged. Consultants shall reputed company the work as independent contractors in a personal reputed company, and not as a representative of any entity or authority.  The execution of the work under a consultant contract does not create an employer/employee relationship between reputed company and the Consultant. reputed company/WHO shall have no responsibility whatsoever for any taxes, duties, reputed company reputed company contributions or other contributions payable by the Consultant.  The Consultant shall be solely responsible for withholding and paying any taxes, duties, reputed company reputed company contributions and any other contributions which are applicable to the Consultant in reputed company location/jurisdiction in which the work hereunder is performed, and the Consultant shall not be entitled to any reimbursement thereof by reputed company/WHO. Apply To This Job